PDS Biotechnology Corporation (PDSB)
NASDAQ: PDSB · Real-Time Price · USD
0.7200
+0.0056 (0.78%)
At close: Aug 4, 2026, 4:00 PM EDT
0.7520
+0.0320 (4.44%)
After-hours: Aug 4, 2026, 7:35 PM EDT
PDS Biotechnology Market Cap
PDS Biotechnology has a market cap or net worth of $40.19 million as of August 4, 2026. Its market cap has decreased by -19.34% in one year.
Market Cap
40.19M
Enterprise Value
34.39M
1-Year Change
-19.34%
Ranking
Category
Stock Price
$0.72
ChartMarket Cap Chart
Since March 18, 2019, PDS Biotechnology's market cap has decreased from $45.51M to $40.19M, a decrease of -11.70%. That is a compound annual growth rate of -1.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 40.19M | -4.60% |
| Dec 31, 2025 | 42.12M | -30.92% |
| Dec 31, 2024 | 60.98M | -60.56% |
| Dec 29, 2023 | 154.61M | -58.92% |
| Dec 30, 2022 | 376.31M | 63.37% |
| Dec 31, 2021 | 230.35M | 383.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| RenovoRx | 43.22M |
| Hyperion DeFi | 40.02M |
| eXoZymes | 39.43M |
| Radiopharm Theranostics | 38.61M |
| Dyadic International | 38.26M |
| Apollomics | 37.87M |
| Veru Inc. | 35.95M |
| Genenta Science | 35.15M |